Rapport Therapeutics develops precision neuromedicines that utilize Receptor Associate Proteins (RAPs) to target and regulate neuronal receptor complexes. Their lead program, RAP-219, focuses on treating focal epilepsy, while also exploring applications for neuropathic pain and bipolar disorder.
No jobs found. Subscribe below to get notified when we find something for you.
Searching